Oxford Immunotec宣布捐赠结核感染检测试剂，以帮助区分中国新型冠状病毒感染与结核病
January 23, 2020 04:00 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Oxford...
Oxford Immunotec Announces Donation in Support of Coronavirus Testing Efforts to Help Differentiate Tuberculosis from the New China Virus
January 23, 2020 04:00 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced...
Oxford Immunotec to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 06, 2020 09:15 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...
Oxford Immunotec to Participate in Two Investor Conferences
November 25, 2019 09:15 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...
Oxford Immunotec Reports Third Quarter 2019 Financial Results
November 05, 2019 07:00 ET
|
Oxford Immunotec Global PLC
Third quarter revenue of $21.2 million, an increase of 32% compared to prior year periodGross margin of 73%, an increase of 150 basis points from the prior year periodPositive net income of $0.7...
Oxford Immunotec Schedules Third Quarter 2019 Earnings Release and Conference Call for November 5, 2019
October 22, 2019 09:15 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
Oxford Immunotec to Participate in Two Upcoming Investor Conferences
August 21, 2019 09:15 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), or the Company, a global, high-growth diagnostics company, today announced...
Oxford Immunotec Reports Second Quarter 2019 Financial Results
August 06, 2019 07:00 ET
|
Oxford Immunotec Global PLC
Second quarter revenue of $19.6 million, an increase of 18% compared to prior year periodGross margin of 72.4%, reflecting our shift towards a pure-play kit businessPositive net income of $0.6 million...
Oxford Immunotec Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019
July 18, 2019 15:35 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...
Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman
June 24, 2019 11:35 ET
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...